In response to the above situation, chemotherapy is suspended and granulocyte colony-stimulating factor (G-CSF) is given to stimulate bone marrow hematopoiesis to treat neutropenia, while compound glycyrrhetinic acid is used for liver protection and enzyme reduction to treat liver dysfunction. Here, CSF3 is linked to neutropenia.